The Next Generation of Obesity Drugs

The following is a summary of a story by Shantell Kirkendoll on Duke University School of Medicine. For decades, glucagon, a peptide hormone of the pancreas, has been recognized in biology texts for raising blood sugar levels, while insulin, its naturally occurring counterpart in the pancreas, lowers blood sugar. But a Duke University School of Medicine researcher argues that glucagon may be the next big thing in weight loss drugs. Jonathan Campbell, a metabolism and diabetes researcher and associate professor of medicine, presented his findings at the American Diabetes…